{"content":"<li class=\"n-box-item date-title\" data-end=\"1384232399\" data-start=\"1384146000\" data-txt=\"Friday, December 20, 2019\">Monday, November 11, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1404712\" data-ts=\"1384211990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTI\" target=\"_blank\">NTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404712-northern-tier-energy-misses-by-0_19-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Tier Energy misses by $0.19, beats on revenue</a></h4><ul>\n<li>Northern Tier Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/NTI\" title=\"Northern Tier Energy\">NTI</a>): Q3 EPS of $0.30 <font color=\"red\">misses by $0.19</font>.</li>\n<li>Revenue of $1.44B (+14% Y/Y) <font color=\"green\">beats by $600M</font>.</li>\n<li>Shares <font color=\"red\">-2.8%</font> AH. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1404712\" data-linked=\"Northern Tier Energy misses by $0.19, beats on revenue\" data-tweet=\"$NTI - Northern Tier Energy misses by $0.19, beats on revenue https://seekingalpha.com/news/1404712-northern-tier-energy-misses-by-0_19-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1404712-northern-tier-energy-misses-by-0_19-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1404602\" data-ts=\"1384209584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404602-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top Gainers, as of 5:15 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/FTEK\" title=\"Fuel Tech, Inc.\">FTEK</a> <font color=\"green\">+16.8%</font>. <a href=\"https://seekingalpha.com/symbol/SLTM\" title=\"Solta Medical, Inc\">SLTM</a> <font color=\"green\">+14.7%</font>. <a href=\"https://seekingalpha.com/symbol/VSAT\" title=\"Viasat, Inc.\">VSAT</a> <font color=\"green\">+4.0%</font>. <a href=\"https://seekingalpha.com/symbol/RNDY\" title=\"Roundy's Supermarkets, Inc\">RNDY</a> <font color=\"green\">+2.4%</font>. <a href=\"https://seekingalpha.com/symbol/SKYW\" title=\"SkyWest, Inc.\">SKYW</a> <font color=\"green\">+2.4%</font>.</li>\n<li>\n<b>Top Losers, as of 5:15 p.m.</b>: <a href=\"https://seekingalpha.com/symbol/HOLX\" title=\"Hologic, Inc.\">HOLX</a> <font color=\"red\">-7.8%</font>. <a href=\"https://seekingalpha.com/symbol/RAX\" title=\"Rackspace Hosting, Inc.\">RAX</a> <font color=\"red\">-6.5%</font>. <a href=\"https://seekingalpha.com/symbol/TSU\" title=\"TIM Participações S.A.\">TSU</a> <font color=\"red\">-6.2%</font>. <a href=\"https://seekingalpha.com/symbol/LEE\" title=\"Lee Enterprises, Incorporated\">LEE</a> <font color=\"red\">-5.2%</font>. <a href=\"https://seekingalpha.com/symbol/NSM\" title=\"Nationstar Mortgage Holdings\">NSM</a> <font color=\"red\">-4.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1404602\" data-linked=\"After hours Gainers / Losers\" data-tweet=\"$FTEK $SLTM $VSAT - After hours Gainers / Losers https://seekingalpha.com/news/1404602-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1404602-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1404402\" data-ts=\"1384207060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404402-t-mobile-usa-announces-66_15m-share-stock-offering-shares-minus-3_4-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile USA announces 66.15M-share stock offering, shares -3.4% AH</a></h4><ul>\n<li>At current levels, T-Mobile's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a>) offering would yield proceeds of $1.72B. The #4 U.S. carrier says it will use the proceeds for \"general corporate purposes,\" including capex and opportunistic spectrum purchases. Underwriters have an option to buy another 6.615M shares. (PR)</li>\n<li>T-Mobile ended Q3 with $2.4B in cash/equivalents, and $7B in debt. The company has been <a href=\"https://seekingalpha.com/currents/post/1385192\" target=\"_blank\">spending aggressively</a> to expand its 4G network (with the goal of neutralizing Verizon/AT&amp;T's head start), as well as to grow its retail presence.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1404402\" data-linked=\"T-Mobile USA announces 66.15M-share stock offering, shares -3.4% AH\" data-tweet=\"$TMUS - T-Mobile USA announces 66.15M-share stock offering, shares -3.4% AH https://seekingalpha.com/news/1404402-t-mobile-usa-announces-66_15m-share-stock-offering-shares-minus-3_4-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1404402-t-mobile-usa-announces-66_15m-share-stock-offering-shares-minus-3_4-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1404362\" data-ts=\"1384206579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLTM\" target=\"_blank\">SLTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404362-solta-medical-outlines-restructuring-hires-piper-to-evaluate-alternatives\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solta Medical outlines restructuring, hires Piper to evaluate alternatives</a></h4><ul>\n<li>Solta Medical (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SLTM\" title=\"Solta Medical, Inc\">SLTM</a>) rises <font color=\"green\">17%</font> AH despite missing estimates with <a href=\"https://seekingalpha.com/currents/post/1404282\" target=\"_blank\">Q3 results</a><a href=\"https://seekingalpha.com/currents/post/1404282\" target=\"_blank\"></a>.</li>\n<li>A sizable top-line miss is attributed to \"lower average selling prices on systems, primarily on the Liposonix  products, and a higher proportion of international distributor business.\"</li>\n<li>Cash as of September 30: $7.7M</li>\n<li>The company announces a new operating plan for 2014 which includes: Y/Y revenue growth, double-digit operating profit, and the maximization of cash flow from operations.</li>\n<li>SLTM plans to cut annual expenses by $12M. Cost reductions include work force cuts.</li>\n<li>\n<em>The board has hired Piper Jaffray to advise on the evaluation of strategic alternatives.</em> (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1404362\" data-linked=\"Solta Medical outlines restructuring, hires Piper to evaluate alternatives\" data-tweet=\"$SLTM - Solta Medical outlines restructuring, hires Piper to evaluate alternatives https://seekingalpha.com/news/1404362-solta-medical-outlines-restructuring-hires-piper-to-evaluate-alternatives?source=tweet\" data-url=\"https://seekingalpha.com/news/1404362-solta-medical-outlines-restructuring-hires-piper-to-evaluate-alternatives\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1404142\" data-ts=\"1384204258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOLX\" target=\"_blank\">HOLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404142-hologic-beats-by-0_02-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hologic beats by $0.02, misses on revenue</a></h4><ul>     <li>Hologic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HOLX\" title=\"Hologic, Inc.\">HOLX</a>): FQ4 EPS of $0.39 <font color=\"green\">beats by $0.02</font>.</li>\n<li>Revenue of $622.1M <font color=\"red\">misses by $2.3M</font>. Shares  <font color=\"red\">-6.03%</font> . (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1404142\" data-linked=\"Hologic beats by $0.02, misses on revenue\" data-tweet=\"$HOLX - Hologic beats by $0.02, misses on revenue https://seekingalpha.com/news/1404142-hologic-beats-by-0_02-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1404142-hologic-beats-by-0_02-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1404112\" data-ts=\"1384204083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAX\" target=\"_blank\">RAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404112-rackspace-misses-by-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rackspace misses by $0.04, beats on revenue</a></h4><ul>     <li>Rackspace (NYSE:<a href=\"https://seekingalpha.com/symbol/RAX\" title=\"Rackspace Hosting, Inc.\">RAX</a>): FQ3 EPS of $0.11 <font color=\"red\">misses by $0.04</font>.</li>\n<li>Revenue of $389.0M (+16% Y/Y) <font color=\"green\">beats by $1.5M</font>. Shares  <font color=\"red\">-7.85%</font> . (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1404112\" data-linked=\"Rackspace misses by $0.04, beats on revenue\" data-tweet=\"$RAX - Rackspace misses by $0.04, beats on revenue https://seekingalpha.com/news/1404112-rackspace-misses-by-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1404112-rackspace-misses-by-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1404062\" data-ts=\"1384203566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FE\" target=\"_blank\">FE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404062-firstenergys-plans-another-2_8b-in-spending-shares-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FirstEnergy&#39;s plans another $2.8B in spending, shares slide</a></h4><ul>     <li>FirstEnergy (<a href=\"https://seekingalpha.com/symbol/FE\" title=\"FirstEnergy Corp\">FE</a> <font color=\"red\">-5.9%</font>) is <a href=\"http://www.cleveland.com/business/index.ssf/2013/11/firstenergy_to_rebuild_its_tra.html\" target=\"_blank\">planning to spend another $2.8B</a> in the next five years to  upgrade its Ohio and western Pennsylvania high-voltage power lines and equipment, projecting that the rebuilding will lead to a 20% annual growth in its transmission net income.</li>     <li>Coming on top of $700M in upgrades already planned, the massive rebuilding is part of FE's larger plan to close old power plants and to rein in the company's unregulated subsidiary.</li>     <li>Moody's says FE's transmission-focused investment strategy that calls for the use of the  company's equity as a major funding source is a <a href=\"https://www.moodys.com/research/Moodys-FirstEnergys-focus-on-transmission-investment-credit-positive-but-concerns--PR_286436?WT.mc_id=NLTITLE_YYYYMMDD_PR_286436\" target=\"_blank\">credit positive</a>, but not sufficient to trigger a revision in its current negative outlook.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1404062\" data-linked=\"FirstEnergy&#39;s plans another $2.8B in spending, shares slide\" data-tweet=\"$FE - FirstEnergy&#39;s plans another $2.8B in spending, shares slide https://seekingalpha.com/news/1404062-firstenergys-plans-another-2_8b-in-spending-shares-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/1404062-firstenergys-plans-another-2_8b-in-spending-shares-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1404042\" data-ts=\"1384202799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404042-annaly-slides-further\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Annaly slides further</a></h4><ul>\n<li>Annaly Capital (<a href=\"https://seekingalpha.com/symbol/NLY\" title=\"Annaly Capital Management, Inc.\">NLY</a> <font color=\"red\">-2.3%</font>) takes out not just a new 52-week low today, but slides to its lowest price since the 2001 - when the yield curve was negative. Yes, higher rates have hurt the mREITs (<a href=\"https://seekingalpha.com/symbol/REM\" title=\"iShares Mortgage Real Estate Capped ETF\">REM</a> <font color=\"red\">-1.2%</font>), but some more than others. Who cut leverage at the wrong time? Who put on more hedges with the 10-year at 2.25% (good), and who put them on at 3% (not so good)?</li>\n<li>The Q3 earnings call (<a href=\"https://seekingalpha.com/article/1824952-annaly-capital-management-management-discusses-q3-2013-results-earnings-call-transcript\" target=\"_blank\">transcript</a>) revealed a management hunkered down - talking leverage to 5.4x (from 6.2) and hedges to 74% of assets from 56%. Core earnings have been in the range of $0.28-$0.32 per share for the last five quarters (compared to current $0.35 dividend), so a payout in the area of $0.30 seems likely.</li>\n<li>CEO Denehan-Norris: \"I don't think anybody, given how many people got it wrong, can sit here and sit before you and say that they know exactly when [the Fed is going] to taper and they know exactly what the impacts are going to be on mortgage assets and all assets in particular.\"</li>\n<li>Annaly Q3 <a href=\"https://seekingalpha.com/symbol/nly/currents/earnings\" target=\"_blank\">earnings coverage</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1404042\" data-linked=\"Annaly slides further\" data-tweet=\"$NLY $NLY $REM - Annaly slides further https://seekingalpha.com/news/1404042-annaly-slides-further?source=tweet\" data-url=\"https://seekingalpha.com/news/1404042-annaly-slides-further\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1404032\" data-ts=\"1384202686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTATQ\" target=\"_blank\">GTATQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404032-gt-advanced-rubicon-surge-again-as-apple-buzz-grows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GT Advanced, Rubicon surge again as Apple buzz grows</a></h4><ul>\n<li>A <a href=\"http://www.cnbc.com/id/101183712\" target=\"_blank\">CNBC column</a> about GT Advanced's (GTAT <font color=\"green\">+8%</font>) huge <a href=\"https://seekingalpha.com/currents/post/1383152\" target=\"_blank\">sapphire supply deal</a> with Apple provides a few favorable quotes about the tie-up, as well as sapphire's long-term potential as a display cover glass. An in-depth <a href=\"http://techcrunch.com/2013/11/08/why-apple-bought-578m-worth-of-sapphire-in-advance/\" target=\"_blank\">TechCrunch piece</a> also provides an upbeat take on the implications of the Apple deal.</li>\n<li>It also noted a forecast from Taiwanese research firm LEDInsight that predicts the Apple deal will result in major sapphire shortages (10%+) in 2015, and even bigger ones (20%+) in 2016. As those keeping track of Rubicon's (<a href=\"https://seekingalpha.com/symbol/RBCN\" title=\"Rubicon Technology, Inc.\">RBCN</a> <font color=\"green\">+9%</font>) wafer prices and <a href=\"https://seekingalpha.com/currents/post/1006671\" target=\"_blank\">gross margin</a> are well aware, the sapphire industry has been in a state of oversupply in recent years.</li>\n<li>Also: A <a href=\"https://seekingalpha.com/currents/post/1402002\" target=\"_blank\">Bloomberg report</a> states Apple plans to launch 4.7\" and 5.5\" iPhones featuring curved displays in 2H14. If/when sapphire is used to cover iPhone displays, larger screen sizes will require the use of more material.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1404032\" data-linked=\"GT Advanced, Rubicon surge again as Apple buzz grows\" data-tweet=\"$GTATQ $GTATQ $RBCN - GT Advanced, Rubicon surge again as Apple buzz grows https://seekingalpha.com/news/1404032-gt-advanced-rubicon-surge-again-as-apple-buzz-grows?source=tweet\" data-url=\"https://seekingalpha.com/news/1404032-gt-advanced-rubicon-surge-again-as-apple-buzz-grows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403992\" data-ts=\"1384201564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JASO\" target=\"_blank\">JASO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403992-solar-stocks-jump-again-as-positive-sentiment-prevails\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solar stocks jump again as positive sentiment prevails</a></h4><ul>     <li>Solar stocks are bouncing back strongly today following <a href=\"https://seekingalpha.com/currents/post/1397202\" target=\"_blank\">last Thursday's </a>SolarCity-led selloff. Though there's no major news trigger for today's gains, industry sentiment has been increasingly positive thanks to <a href=\"https://seekingalpha.com/currents/post/1382312\" target=\"_blank\">good earnings news</a>, optimism about 2014 demand, and signs government support remains healthy.</li>     <li>\n<a href=\"http://www.newenergyworldnetwork.com/investor-news/renewable-energy-news/by-technology/solar/china-boosts-2014-solar-target-to-12gw.html\" target=\"_blank\">China has lifted</a> its 2014 solar installation target to 12GW from 10GW, albeit while keeping its 2015 cumulative installation target intact at 35GW. Meanwhile, Solarbuzz is predicting long-struggling Europe will stabilize in 1H14, and <a href=\"http://www.digitimes.com/news/a20131107PR205.html\" target=\"_blank\">return to growth</a> in 2H14. Germany and the U.K. are expected to account for half of regional demand.</li>     <li>JA Solar (<a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"green\">+10.1%</font>), which has announced a new 70MW module supply deal, is among today's big winners. Others: <a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"green\">+10.5%</font>. <a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a> <font color=\"green\">+4.2%</font>. SCTY <font color=\"green\">+6.7%</font>. <a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"green\">+7.9%</font>. <a href=\"https://seekingalpha.com/symbol/ENPH\" title=\"Enphase Energy Inc.\">ENPH</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"green\">+6.7%</font>. <a href=\"https://seekingalpha.com/symbol/CSUN\" title=\"China Sunergy Co., Ltd.\">CSUN</a> <font color=\"green\">+8.8%</font>. <a href=\"https://seekingalpha.com/symbol/STRI\" title=\"STR Holdings, Inc.\">STRI</a> <font color=\"green\">+7.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1403992\" data-linked=\"Solar stocks jump again as positive sentiment prevails\" data-tweet=\"$JASO $JASO $JKS - Solar stocks jump again as positive sentiment prevails https://seekingalpha.com/news/1403992-solar-stocks-jump-again-as-positive-sentiment-prevails?source=tweet\" data-url=\"https://seekingalpha.com/news/1403992-solar-stocks-jump-again-as-positive-sentiment-prevails\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403952\" data-ts=\"1384200956\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMGN\" target=\"_blank\">IMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403952-immunogen-shakes-off-morgan-stanley-downgrade-to-trade-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoGen shakes off Morgan Stanley downgrade to trade higher</a></h4><ul>\n<li>ImmunoGen (<a href=\"https://seekingalpha.com/symbol/IMGN\" title=\"ImmunoGen, Inc.\">IMGN</a> <font color=\"green\">+9.8%</font>) bounces back from early losses to trade sharply higher.</li>\n<li>Early weakness was likely attributable to Morgan Stanley, where analysts <a href=\"http://www.streetinsider.com/Downgrades/Morgan+Stanley+Downgrades+Immunogen+Inc.+%28IMGN%29+to+Underweight/8868428.html\" target=\"_blank\">downgraded</a> the shares to Underweight with a $9.50 price target <a href=\"https://twitter.com/thenotablecalls/status/399890034364399616\" target=\"_blank\">citing</a> trouble with <a href=\"https://seekingalpha.com/currents/post/1384852\" target=\"_blank\">IMGN901</a>.</li>\n<li>See also: IMGN <a href=\"https://seekingalpha.com/currents/post/1402492\" target=\"_blank\">signs</a> third licensing agreement with Novartis.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403952\" data-linked=\"ImmunoGen shakes off Morgan Stanley downgrade to trade higher\" data-tweet=\"$IMGN - ImmunoGen shakes off Morgan Stanley downgrade to trade higher https://seekingalpha.com/news/1403952-immunogen-shakes-off-morgan-stanley-downgrade-to-trade-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1403952-immunogen-shakes-off-morgan-stanley-downgrade-to-trade-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403892\" data-ts=\"1384199755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NCR\" target=\"_blank\">NCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403892-ncr-slips-after-providing-2015-2016-eps-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NCR slips after providing 2015, 2016 EPS targets</a></h4><ul>\n<li>NCR (<a href=\"https://seekingalpha.com/symbol/NCR\" title=\"NCR Corporation\">NCR</a> <font color=\"red\">-2.4%</font>) has used its investor day to establish a 2015 EPS guidance range of $3.60-$3.80, and a 2016 range of $4.10-$4.50. The company's <a href=\"https://seekingalpha.com/currents/post/1358862\" target=\"_blank\">2013 EPS guidance range</a> of $2.70-$2.80 has been reiterated.</li>\n<li>The point-of-sale hardware vendor is also forecasting 2016 revenue of $7.3B-$7.7B; the 2013 consensus is currently at $6.22B, and the 2014 consensus at $6.59B. Gross margin is expected to rise 300 bps from 2013 levels, and (thanks in part to the <a href=\"https://seekingalpha.com/currents/post/689051\" target=\"_blank\">Retalix acquisition</a>) software is expected to account for 16%-17% of revenue, up from 12% in 2013 and 7% in 2010. 37% of revenue is expected to come from recurring streams.</li>\n<li>NCR also predicts its pension funding gap will decline to $100M in 2014 from $250M in 2013, and that its free cash flow impact will decline to $50m-$75M from 2013's $87M and 2012's $152M.</li>\n<li>The company's core financial services vertical is only expected to see a 4%-6% revenue CAGR from 2013-2016. But hospitality is expected to post a 14%-16% CAGR, retail an 8%-10% CAGR, and emerging industries a 10%-13% CAGR.</li>\n<li>\n<a href=\"http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MjEwODg4fENoaWxkSUQ9LTF8VHlwZT0z&amp;t=1\" target=\"_blank\">Investor day slides</a> (.pdf), <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&amp;c=83840&amp;eventID=4938437\" target=\"_blank\">webcast</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403892\" data-linked=\"NCR slips after providing 2015, 2016 EPS targets\" data-tweet=\"$NCR - NCR slips after providing 2015, 2016 EPS targets https://seekingalpha.com/news/1403892-ncr-slips-after-providing-2015-2016-eps-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/1403892-ncr-slips-after-providing-2015-2016-eps-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403882\" data-ts=\"1384199198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WINT\" target=\"_blank\">WINT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403882-piper-likes-discovery-labs-on-surfaxin-aerosurf-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper likes Discovery Labs on Surfaxin, Aerosurf potential</a></h4><ul>\n<li>Premarket <a href=\"https://seekingalpha.com/currents/post/1403072\" target=\"_blank\">strength</a> in Discovery Laboratories (DSCO <font color=\"green\">+13.9%</font>) has held up throughout the day, with the shares higher by double-digits thanks to an upgrade from Piper Jaffray. <br>\n</li>\n<li>\"With north of $100M in peak sales potential and a lean hospital-based  U.S. sales organization focused on neonatologists, we believe DSCO can  <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4068592/update-piper-jaffray-initiates-coverage-on-discovery-lab\" target=\"_blank\">reach profitability</a> on <a href=\"https://seekingalpha.com/currents/search?query=Surfaxin\" target=\"_blank\">Surfaxin</a> alone,\" analyst David Amsellem says.</li>\n<li>Amsellem also calls Aerosurf (that's the Phase 2 aerosol surfactant) a \"next-generation shot-on-goal in RDS [with a] transformative peak sales opportunity of north of $300M.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403882\" data-linked=\"Piper likes Discovery Labs on Surfaxin, Aerosurf potential\" data-tweet=\"$WINT - Piper likes Discovery Labs on Surfaxin, Aerosurf potential https://seekingalpha.com/news/1403882-piper-likes-discovery-labs-on-surfaxin-aerosurf-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/1403882-piper-likes-discovery-labs-on-surfaxin-aerosurf-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403842\" data-ts=\"1384198123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MWA\" target=\"_blank\">MWA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403842-goldman-no-longer-bearish-on-mueller-water-products-shares-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman no longer bearish on Mueller Water Products, shares rise</a></h4><ul>\n<li>Shares of Mueller Water Products (<a href=\"https://seekingalpha.com/symbol/MWA\" title=\"Mueller Water Products, Inc.\">MWA</a> <font color=\"green\">+3%</font>) are getting a lift from an <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4068802/update-goldman-sachs-upgrades-mueller-water-products-on-\" target=\"_blank\">upgrade</a> to Neutral from Sell at Goldman.</li>\n<li>\"We now see 5% upside to FY14  consensus EBITDA due to higher US non-res capex and lower input costs,\" analyst Jerry Revich says, adding that he has \"stayed negative for too long as municipal water spending and margins have recovered.\"</li>\n<li>Adjusted operating margin for the MRQ rose 430 bps Y/Y.</li>\n<li>See also: Revich Q&amp;A with management on FQ4 CC (<a href=\"https://seekingalpha.com/article/1788182-mueller-water-products-management-discusses-q4-2013-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403842\" data-linked=\"Goldman no longer bearish on Mueller Water Products, shares rise\" data-tweet=\"$MWA - Goldman no longer bearish on Mueller Water Products, shares rise https://seekingalpha.com/news/1403842-goldman-no-longer-bearish-on-mueller-water-products-shares-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/1403842-goldman-no-longer-bearish-on-mueller-water-products-shares-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403832\" data-ts=\"1384198045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALJ\" target=\"_blank\">ALJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403832-alon-alon-partners-buck-refiner-weakness-on-credit-suisse-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alon, Alon Partners buck refiner weakness on Credit Suisse upgrade</a></h4><ul>     <li>Alon USA Energy (<a href=\"https://seekingalpha.com/symbol/ALJ\" title=\"Alon USA Energy, Inc.\">ALJ</a> <font color=\"green\">+8.2%</font>) and Alon Partners (<a href=\"https://seekingalpha.com/symbol/ALDW\" title=\"Alon USA Partners\">ALDW</a> <font color=\"green\">+4.1%</font>) are surging, despite weakness today in the broader refining sector, as Credit Suisse <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/11/11/alon-usa-bucks-refiner-weakness-on-credit-suisse-upgrade/\" target=\"_blank\">upgrades</a> shares.</li>     <li>ALJ could be worth up to $15/share, including the $2.25/share expected contribution from the Bakersfield start-up - delivery of this project is key; at current levels, the stock still provides ~20% upside in the scenario where Bakersfield does not proceed or ~40% if it does.</li>     <li>On ALDW, for investors willing to overlook the possibility of no distribution payout in Q4 2013 and Q1 2014, the firm says the rolling 12-month potential forward yield starting in Q2 2014 is 15% and rises to ~20% by Q4.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1403832\" data-linked=\"Alon, Alon Partners buck refiner weakness on Credit Suisse upgrade\" data-tweet=\"$ALJ $ALJ $ALDW - Alon, Alon Partners buck refiner weakness on Credit Suisse upgrade https://seekingalpha.com/news/1403832-alon-alon-partners-buck-refiner-weakness-on-credit-suisse-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1403832-alon-alon-partners-buck-refiner-weakness-on-credit-suisse-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403792\" data-ts=\"1384197124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YPF\" target=\"_blank\">YPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403792-ypf-says-argentina-discovery-could-hold-15m-barrels-of-oil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YPF says Argentina discovery could hold 15M barrels of oil</a></h4><ul>     <li>Argentina's YPF (<a href=\"https://seekingalpha.com/symbol/YPF\" title=\"YPF Sociedad Anonima\">YPF</a> <font color=\"green\">+5.4%</font>) says it has made a <a href=\"http://www.buenosairesherald.com/article/144903/ypf-finds-oil-in-mendoza\" target=\"_blank\">conventional oil discovery</a> in the Mendoza province which it claims will add 15M barrels of crude to its reserves.</li>     <li>The discovery would imply a 2.5% increase in YPF\u2019s total proven reserves at the end of last year of 590M barrels of oil.</li>     <li>The find also demonstrates how conventional discoveries remain an important part of YPF\u2019s portfolio even as attention is focused on the country\u2019s potential in unconventional resources, such as those located in the <a href=\"https://seekingalpha.com/currents/search?query=vaca+muerta\" target=\"_blank\">Vaca Muerta</a> formation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1403792\" data-linked=\"YPF says Argentina discovery could hold 15M barrels of oil\" data-tweet=\"$YPF - YPF says Argentina discovery could hold 15M barrels of oil https://seekingalpha.com/news/1403792-ypf-says-argentina-discovery-could-hold-15m-barrels-of-oil?source=tweet\" data-url=\"https://seekingalpha.com/news/1403792-ypf-says-argentina-discovery-could-hold-15m-barrels-of-oil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403782\" data-ts=\"1384196886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETR\" target=\"_blank\">ETR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403782-isi-cuts-entergy-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ISI cuts Entergy to Neutral</a></h4><ul>\n<li>ISI's Greg Gordon cuts Entergy (<a href=\"https://seekingalpha.com/symbol/ETR\" title=\"Entergy Corporation\">ETR</a> <font color=\"red\">-2%</font>) to Neutral from Buy after reviewing the information contained in the company's <a href=\"http://www.eei.org/about/meetings/meeting.aspx?EEIEventId=B235790E-A81F-4200-BA0B-D4A66FBBF04F\" target=\"_blank\">EEI</a> presentation.</li>\n<li>Citing \"three valuable modeling parameters\" (CAGR guidance for utilities, EBITDA forecast for the merchant side, and a range for \"other expenses\"), Gordon lowers his FY14 and FY15 EPS estimates to $5.10 (from $5.15) and $5 (from $5.30).</li>\n<li>Price target cut to $64 from $70.</li>\n<li>Full ETR EEI presentation is <a href=\"http://investor.shareholder.com/common/download/download.cfm?companyid=ETR&amp;fileid=705310&amp;filekey=d1272955-1018-4e84-be92-c9f214e683be&amp;filename=EEI%20Presentation%20Nov%202013.pdf\" target=\"_blank\">here</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403782\" data-linked=\"ISI cuts Entergy to Neutral\" data-tweet=\"$ETR - ISI cuts Entergy to Neutral https://seekingalpha.com/news/1403782-isi-cuts-entergy-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/1403782-isi-cuts-entergy-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403752\" data-ts=\"1384195928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWBO\" target=\"_blank\">NWBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403752-northwest-biotherapeutics-soars-on-heavy-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northwest Biotherapeutics soars on heavy volume</a></h4><ul><li>Shares of Northwest Biotherapeutics (<a href='https://seekingalpha.com/symbol/NWBO' title='Northwest Biotherapeutics, Inc.'>OTCQB:NWBO</a> <font color='green'>+31.4%</font>) move sharply higher on the session.</li><li>More than 4M shares have traded thus far, against a 10-day average of just 365K.</li></ul><div class=\"tiny-share-widget\" data-id=\"1403752\" data-linked=\"Northwest Biotherapeutics soars on heavy volume\" data-tweet=\"$NWBO - Northwest Biotherapeutics soars on heavy volume https://seekingalpha.com/news/1403752-northwest-biotherapeutics-soars-on-heavy-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/1403752-northwest-biotherapeutics-soars-on-heavy-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403712\" data-ts=\"1384194207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCRX\" target=\"_blank\">BCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403712-hae-plays-move-higher-after-shire-viropharma-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HAE plays move higher after Shire/ViroPharma deal</a></h4><ul><li>After trading near the flat line early on, shares of BioCryst (<a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a> <font color='green'>+3.2%</font>) are now moving notably higher on the session. The stock is on watch today after Shire's <a href=\"https://seekingalpha.com/currents/search?query=viropharma+shire\" target=\"_blank\">deal</a> for ViroPharma, as BCRX is working on oral HAE treatments which could eventually challenge <a href=\"https://seekingalpha.com/currents/search?query=Cinryze\" target=\"_blank\">Cinryze.</a> </li><li>Other hereditary angioedema plays:&nbsp;<a href='https://seekingalpha.com/symbol/DYAX' title='Dyax Corp.'>DYAX</a> is <font color='green'>+4.6%</font> and <a href='https://seekingalpha.com/symbol/SLXP' title='Salix Pharmaceuticals, Ltd.'>SLXP</a>&mdash; which obtained the pipeline asset Ruconest in the <a href=\"https://seekingalpha.com/currents/post/1398322\" target=\"_blank\">Santarus deal</a> &mdash; is <font color='green'>+1.4%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"1403712\" data-linked=\"HAE plays move higher after Shire/ViroPharma deal\" data-tweet=\"$BCRX $BCRX $DYAX - HAE plays move higher after Shire/ViroPharma deal https://seekingalpha.com/news/1403712-hae-plays-move-higher-after-shire-viropharma-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1403712-hae-plays-move-higher-after-shire-viropharma-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403682\" data-ts=\"1384192674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBL\" target=\"_blank\">NBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403682-rosetta-resources-on-the-rise-as-stifel-upgrades-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosetta Resources on the rise as Stifel upgrades to Buy</a></h4><ul>     <li>Rosetta Resources (<a href=\"https://seekingalpha.com/symbol/ROSE\" title=\"Rosehill Resources Inc.\">ROSE</a> <font color=\"green\">+3.2%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4068414/update-stifel-upgrades-rosetta-resources-on-attractive-e\" target=\"_blank\">upgraded to Buy</a> from Hold with a $65 target price at Stifel, which says last week's drop in the stock was due mostly to overly optimistic expectations heading into the quarter as well as slightly <a href=\"https://seekingalpha.com/currents/post/1392402\" target=\"_blank\">reduced</a>  production and cash flow expectations, creating an attractive entry point for investors.</li>\n<li>The firm expects accelerating sequential production growth given the  backlog in the Eagle Ford and the addition of Permian/Eagle Ford rigs  heading into 2014.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403682\" data-linked=\"Rosetta Resources on the rise as Stifel upgrades to Buy\" data-tweet=\"$NBL - Rosetta Resources on the rise as Stifel upgrades to Buy https://seekingalpha.com/news/1403682-rosetta-resources-on-the-rise-as-stifel-upgrades-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/1403682-rosetta-resources-on-the-rise-as-stifel-upgrades-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403672\" data-ts=\"1384192555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLAC\" target=\"_blank\">KLAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403672-kla-tencor-slides-on-susquehanna-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KLA-Tencor slides on Susquehanna downgrade</a></h4><ul>\n<li>Susquehanna's <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4068912/update-susquehanna-international-group-downgrades-kla-te\" target=\"_blank\">Mehdi Hosseini</a> has cut KLA (<a href=\"https://seekingalpha.com/symbol/KLAC\" title=\"KLA-Tencor Corporation\">KLAC</a> <font color=\"red\">-2.8%</font>) to Negative due to a belief the wafer fab portion of the chip equipment industry will post only 8%-10% 2014 growth at best (well below <a href=\"http://www.gartner.com/newsroom/id/2592316\" target=\"_blank\">Gartner's forecast</a> for 14.9% growth), and that KLA's bookings \"will see a sharp decline\" in calendar Q1 as weakness at top foundry customer TSMC fails to be offset by other clients.</li>\n<li>Hosseini's calendar 2014 EPS estimate is now at $4.30, below a prior $4.53 and a $4.57 consensus. He <a href=\"https://seekingalpha.com/currents/post/1349252\" target=\"_blank\">has also downgraded</a> peer Lam Research to Neutral, but Lam's shares aren't showing serious ill effects.</li>\n<li>KLA shares remain <font color=\"green\">up 32%</font> YTD.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403672\" data-linked=\"KLA-Tencor slides on Susquehanna downgrade\" data-tweet=\"$KLAC - KLA-Tencor slides on Susquehanna downgrade https://seekingalpha.com/news/1403672-kla-tencor-slides-on-susquehanna-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1403672-kla-tencor-slides-on-susquehanna-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403642\" data-ts=\"1384191937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403642-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Top 10 Gainers:</b> <a href='https://seekingalpha.com/symbol/VISN' title='VisionChina Media, Inc.'>VISN</a> <font color='green'>+46%</font>. <a href='https://seekingalpha.com/symbol/NWBO' title='Northwest Biotherapeutics, Inc.'>OTCQB:NWBO</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/VPHM' title=''>VPHM</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/GURE' title='GULF RESOURCES INC'>GURE</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/CMGE' title='China Mobile Games & Entertainment Group Ltd'>CMGE</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ARCW' title='ARC Group Worldwide, Inc.'>ARCW</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CLRX' title='CollabRx, Inc'>CLRX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/BORN' title='China New Borun Corporation'>BORN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/ERB' title='ERBA Diagnostics, Inc.'>ERB</a> <font color='green'>+17%</font>.</li><li><b>Top 10 Losers:</b> ZLCS <font color='red'>-73%</font>. <a href='https://seekingalpha.com/symbol/RDNT' title='RadNet, Inc.'>RDNT</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ECTE' title='Echo Therapeutics'>OTC:ECTE</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/GLCH' title='GLEACHER & CO'>GLCH</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NURO' title='NeuroMetrix, Inc.'>NURO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HNSN' title='Hansen Medical, Inc.'>HNSN</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1403642\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$VISN $NWBO $GOGO - Midday Gainers / Losers https://seekingalpha.com/news/1403642-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1403642-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403622\" data-ts=\"1384191501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DECK\" target=\"_blank\">DECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403622-deckers-pops-on-jefferies-call-100-share-by-year-end\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deckers pops on Jefferies call: $100/share by year-end</a></h4><ul><li>Shares of Deckers Outdoor (<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='green'>+6.4%</font>) pop after Jefferies' Randal Konik (who <a href=\"http://finance.yahoo.com/news/deckers-outdoor-recommended-q3-results-095829269.html\" target=\"_blank\">recommended</a> shares before they surged on <a href=\"https://seekingalpha.com/currents/post/1354722\" target=\"_blank\">Q3 results</a>) <a href=\"https://twitter.com/thenotablecalls/status/399951594835292160\" target=\"_blank\">calls</a> shares at $100 by year-end.</li></ul><div class=\"tiny-share-widget\" data-id=\"1403622\" data-linked=\"Deckers pops on Jefferies call: $100/share by year-end\" data-tweet=\"$DECK - Deckers pops on Jefferies call: $100/share by year-end https://seekingalpha.com/news/1403622-deckers-pops-on-jefferies-call-100-share-by-year-end?source=tweet\" data-url=\"https://seekingalpha.com/news/1403622-deckers-pops-on-jefferies-call-100-share-by-year-end\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403612\" data-ts=\"1384191237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403612-invensense-rises-following-bullish-piper-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InvenSense rises following bullish Piper note</a></h4><ul>\n<li>Piper's <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4069023/piper-jaffray-reiterates-on-invensense-on-more-growth-fa\" target=\"_blank\">Gus Richard</a> sees \"a number of growth catalysts\" for InvenSense (<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a> <font color=\"green\">+3.4%</font>) over the next two years. They include a higher penetration rate at top customer Samsung (currently over 30% of sales), rising optical image stabilization-related gyroscope sales, MEMS microphone growth (<a href=\"https://seekingalpha.com/currents/post/1327302\" target=\"_blank\">previous</a>), better low-end smartphone penetration, and the <a href=\"https://seekingalpha.com/currents/post/1112832\" target=\"_blank\">long-anticipated </a>addition of Apple as a customer.</li>\n<li>In addition, Richard expects deeper product integration and software content gains to offset standard mobile price erosion, and help keep InvenSense's gross margin steady while revenue grows at a 25%-35% clip.</li>\n<li>InvenSense <a href=\"https://seekingalpha.com/currents/post/1367522\" target=\"_blank\">recently tumbled</a> due to the guidance it provided with its Sep. quarter beat. Shares have also been pressured a bit by a <a href=\"http://finance.yahoo.com/news/invensense-prices-150-million-convertible-051503480.html\" target=\"_blank\">$150M convertible debt offering</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403612\" data-linked=\"InvenSense rises following bullish Piper note\" data-tweet=\"$INVN - InvenSense rises following bullish Piper note https://seekingalpha.com/news/1403612-invensense-rises-following-bullish-piper-note?source=tweet\" data-url=\"https://seekingalpha.com/news/1403612-invensense-rises-following-bullish-piper-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403542\" data-ts=\"1384189161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNR\" target=\"_blank\">DNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403542-denbury-resources-says-it-will-not-consider-mlp-options\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Denbury Resources says it will not consider MLP options</a></h4><ul>     <li>Denbury Resources (<a href=\"https://seekingalpha.com/symbol/DNR\" title=\"Denbury Resources Inc.\">DNR</a> <font color=\"red\">-5.6%</font>) is slammed after declaring at its analyst day that it <a href=\"https://twitter.com/billyretweets/status/399927151475953664\" target=\"_blank\">will not form an MLP</a> since such a step would not \"create a sustained increase in value.\"</li>     <li>Investors also may not like some other <a href=\"http://finance.yahoo.com/news/denbury-resources-sees-2014-production-152007932.html\" target=\"_blank\">performance numbers revealed today</a>, such as 2014 expectations for total production at 76.5K-78.5K boe/day, capital spending at $1B and cash flow in the range of -$165M to $85M.</li>     <li>DNR earlier had announced <a href=\"https://seekingalpha.com/currents/post/1402072\" target=\"_blank\">initiation of quarterly dividends</a> and an increase in share repurchase authorization.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1403542\" data-linked=\"Denbury Resources says it will not consider MLP options\" data-tweet=\"$DNR - Denbury Resources says it will not consider MLP options https://seekingalpha.com/news/1403542-denbury-resources-says-it-will-not-consider-mlp-options?source=tweet\" data-url=\"https://seekingalpha.com/news/1403542-denbury-resources-says-it-will-not-consider-mlp-options\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403532\" data-ts=\"1384189152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKM\" target=\"_blank\">LKM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403532-nq-mobile-soars-ahead-of-q3-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NQ Mobile soars ahead of Q3 report</a></h4><ul>\n<li>With tomorrow's Q3 report looming, NQ Mobile (NQ <font color=\"green\">+13.4%</font>) has surged to levels last seen on Nov. 1. Shares are still <font color=\"red\">down 42%</font> from where they traded when Muddy Waters <a href=\"https://seekingalpha.com/currents/post/1353642\" target=\"_blank\">first made</a> its fraud allegations.</li>\n<li>Possibly helping: A Chinese media report (<a href=\"http://translate.google.com/translate?sl=zh-CN&amp;tl=en&amp;js=n&amp;prev=_t&amp;hl=en&amp;ie=UTF-8&amp;u=http%3A%2F%2Fnews.xinhuanet.com%2Fyzyd%2Ftech%2F20131111%2Fc_118089974.htm\" target=\"_blank\">translation</a>) indicating local smartphone OEM Coolpad has confirmed its partnership with NQ. MW and others have <a href=\"http://www.valuewalk.com/2013/11/muddy-waters-chinese-media-exposes-lies-about-nq-mobile/\" target=\"_blank\">questioned the existence</a> of NQ's smartphone app pre-install deals with OEMs such as Lenovo, Huawei, and ZTE.</li>\n<li>Short-covering is probably contributing to today's move. 37% of the float was shorted on Oct. 15, nine days before MW's report arrived.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403532\" data-linked=\"NQ Mobile soars ahead of Q3 report\" data-tweet=\"$LKM - NQ Mobile soars ahead of Q3 report https://seekingalpha.com/news/1403532-nq-mobile-soars-ahead-of-q3-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1403532-nq-mobile-soars-ahead-of-q3-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403482\" data-ts=\"1384187641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403482-transocean-moves-up-on-icahn-deal-capping-12-percent-three-day-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean moves up on Icahn deal, capping 12% three-day rise</a></h4><ul>     <li>Transocean (<a href=\"https://seekingalpha.com/symbol/RIG\" title=\"Transocean Ltd.\">RIG</a> <font color=\"green\">+3.8%</font>) enjoys a nice bump after its <a href=\"https://seekingalpha.com/currents/post/1402122\" target=\"_blank\">deal with Carl Icahn</a> (<a href=\"https://seekingalpha.com/symbol/IEP\" title=\"Icahn Enterprises L.P.\">IEP</a> <font color=\"red\">-6.5%</font>) to raise its dividend and move forward with an MLP structure; RIG also announced an offshore and project management-related cost savings target of $500M by the end of 2015.</li>\n<li>Wells Fargo <a href=\"http://www.streetinsider.com/Analyst+Comments/Transocean+%28RIG%29+is+First+Traditional+Offshore+Driller+to+Pursue+MLP+Initiative%3B+Wells+Comments+on+Icahn+Deal/8869533.html\" target=\"_blank\">likes RIG's aggressiveness</a> in pursuing Icahn's value  enhancing proposals and the collaboration with Icahn that could  imply greater financial discipline going forward.</li>     <li>The dividend news is the <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/11/11/transocean-icahn-best-friends-forever/\" target=\"_blank\">most surprising</a>, Howard Weil says, as RIG mentioned going to its board for MLP approval on its last conference call.</li>     <li>Some of the news may have been <a href=\"https://twitter.com/thenotablecalls/status/399908748568711168\" target=\"_blank\">priced in last week</a>; shares have jumped 12% in three days, so today's gain may prove short-lived.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1403482\" data-linked=\"Transocean moves up on Icahn deal, capping 12% three-day rise\" data-tweet=\"$RIG $RIG $IEP - Transocean moves up on Icahn deal, capping 12% three-day rise https://seekingalpha.com/news/1403482-transocean-moves-up-on-icahn-deal-capping-12-percent-three-day-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/1403482-transocean-moves-up-on-icahn-deal-capping-12-percent-three-day-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403412\" data-ts=\"1384185464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403412-long-rumored-shire-viropharma-deal-looks-like-good-fit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Long-rumored Shire, ViroPharma deal looks like good fit</a></h4><ul>\n<li>Those who follow ViroPharma (<a href=\"https://seekingalpha.com/symbol/VPHM\" title=\"\">VPHM</a> <font color=\"green\">+25.5%</font>) likely aren't too surprised by the Shire (<a href=\"https://seekingalpha.com/symbol/SHPG\" title=\"Shire PLC\">SHPG</a> <font color=\"green\">+1.2%</font>) <a href=\"https://seekingalpha.com/currents/post/1402142\" target=\"_blank\">takeout</a>.</li>\n<li>The acquisition <a href=\"https://seekingalpha.com/currents/search?query=viropharma+shire\" target=\"_blank\">rumors have been flying</a> for months and the deal does appear to make strategic sense given SHPG's existing HAE sales force (<a href=\"https://seekingalpha.com/currents/search?query=Firazyr\" target=\"_blank\">Firazyr</a>). Here's <br>Flemming Ornskov: \"SHPG is uniquely positioned to drive the continued success of <a href=\"https://seekingalpha.com/currents/search?query=Cinryze\" target=\"_blank\">Cinryze</a> ... through our knowledge of the rare disease space, our international infrastructure and our biologics manufacturing expertise.\"  </li>\n<li>SHPG will now be able to offer HAE patients complementary treatments.</li>\n<li>The rare disease business is now expected to comprise ~40% of SHPG's top-line.</li>\n<li>Deutsche's Robyn Karnauskas was pretty close back in September, predicting $52/share in a SHPG bid. Notably, Karnauskas modeled \"100% probability [of] <a href=\"https://seekingalpha.com/currents/search?query=Maribavir\" target=\"_blank\">Maribavir</a> sales in refractory CMV.\" <br>\n</li>\n<li>Notably not moving on the news are shares of BioCryst (<a href=\"https://seekingalpha.com/symbol/BCRX\" title=\"BioCryst Pharmaceuticals, Inc.\">BCRX</a> <font color=\"red\">-0.4%</font>) \u2014 the company is developing <a href=\"https://seekingalpha.com/currents/search?query=bcx-4161\" target=\"_blank\">an oral option</a> for HAE. </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403412\" data-linked=\"Long-rumored Shire, ViroPharma deal looks like good fit\" data-tweet=\"$SHPG $SHPG $BCRX - Long-rumored Shire, ViroPharma deal looks like good fit https://seekingalpha.com/news/1403412-long-rumored-shire-viropharma-deal-looks-like-good-fit?source=tweet\" data-url=\"https://seekingalpha.com/news/1403412-long-rumored-shire-viropharma-deal-looks-like-good-fit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403402\" data-ts=\"1384185428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDD\" target=\"_blank\">DDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403402-3d-printing-plays-rally-to-new-highs-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D printing plays rally to new highs again</a></h4><ul>\n<li>3D Systems (<a href=\"https://seekingalpha.com/symbol/DDD\" title=\"3D Systems Corp.\">DDD</a> <font color=\"green\">+4.8%</font>), Stratasys (<a href=\"https://seekingalpha.com/symbol/SSYS\" title=\"Stratasys, Inc.\">SSYS</a> <font color=\"green\">+3.8%</font>), and <a href=\"https://seekingalpha.com/currents/post/1337742\" target=\"_blank\">newly-public</a> Voxeljet (<a href=\"https://seekingalpha.com/symbol/VJET\" title=\"voxeljet AG\">VJET</a> <font color=\"green\">+9.3%</font>) have made fresh highs yet again, as investor enthusiasm for 3D printer makers refuses to abate. ExOne (<a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a> <font color=\"green\">+2.2%</font>) and CAD/CAM software vendor Cimatron (<a href=\"https://seekingalpha.com/symbol/CIMT\" title=\"Cimatron, Limited\">CIMT</a> <font color=\"green\">+2.5%</font>) are also having good days.</li>\n<li>In spite of big YTD gains, short interests for 3D printer vendors remain elevated. 3D's shares <a href=\"https://seekingalpha.com/currents/post/1401292\" target=\"_blank\">rallied on Friday</a> after the company unveiled a $399 consumer-focused 3D object scanner.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403402\" data-linked=\"3D printing plays rally to new highs again\" data-tweet=\"$DDD $DDD $SSYS - 3D printing plays rally to new highs again https://seekingalpha.com/news/1403402-3d-printing-plays-rally-to-new-highs-again?source=tweet\" data-url=\"https://seekingalpha.com/news/1403402-3d-printing-plays-rally-to-new-highs-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403372\" data-ts=\"1384184736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRI\" target=\"_blank\">CPRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403372-michael-kors-to-the-s-and-p-500-index-this-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Michael Kors to the S&amp;P 500 Index this week</a></h4><ul> <li>Michael Kors (KORS <font color=\"green\">+1.5%</font>) will officially <a href=\"http://www.marketwatch.com/story/previously-announced-sp-500-addition-michael-kors-to-join-index-on-november-12-2013-11-08?reflink=MW_news_stmp\" target=\"_blank\">replace</a> NYSE Euronext on the S&amp;P 500 Index after the close of trading tomorrow.</li> <li>News that the company was being added to the index broke late last month and has helped to improve sentiment on the high-flying retailer even further.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1403372\" data-linked=\"Michael Kors to the S&amp;P 500 Index this week\" data-tweet=\"$CPRI - Michael Kors to the S&amp;P 500 Index this week https://seekingalpha.com/news/1403372-michael-kors-to-the-s-and-p-500-index-this-week?source=tweet\" data-url=\"https://seekingalpha.com/news/1403372-michael-kors-to-the-s-and-p-500-index-this-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403352\" data-ts=\"1384184377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNA\" target=\"_blank\">SYNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403352-synaptics-higher-as-pac-crest-reports-of-galaxy-s5-design-win\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synaptics higher as Pac Crest reports of Galaxy S5 design win</a></h4><ul>\n<li>\n<a href=\"https://twitter.com/thenotablecalls/status/399907043831582720\" target=\"_blank\">Pac Crest</a> thinks Synaptics (<a href=\"https://seekingalpha.com/symbol/SYNA\" title=\"Synaptics Incorporated\">SYNA</a> <font color=\"green\">+3.3%</font>), <a href=\"https://seekingalpha.com/currents/post/895091\" target=\"_blank\">already</a> the touch controller supplier for Samsung's Galaxy S4, has won the touch controller slot for the Galaxy S5, which it expects will launch in early Q2.</li>\n<li>\n<a href=\"https://twitter.com/thenotablecalls/status/399907043831582720\" target=\"_blank\">The firm asserts</a> Synaptics' Hover tech, which enables <a href=\"http://www.talkandroid.com/guides/samsung-galaxy-s-4-guides/how-to-set-up-and-use-air-view-and-air-gestures-on-the-samsung-galaxy-s-4/\" target=\"_blank\">touch-free gestures</a> on the S4 and Samsungs' Galaxy Note hardware, allowed the company to beat out rivals Atmel (<a href=\"https://seekingalpha.com/symbol/ATML\" title=\"Atmel Corporation\">ATML</a> <font color=\"red\">-0.2%</font>), Cypress (<a href=\"https://seekingalpha.com/symbol/CY\" title=\"Cypress Semiconductor Corporation\">CY</a> <font color=\"red\">-1.8%</font>), and South Korea's Melfas, who it thinks can't offer similar functionality. The S4 and Note design wins have contributed to the triple-digit mobile sales growth Synaptics has seen in recent quarters.</li>\n<li>Shares recently sold off due to soft Dec. quarter <a href=\"https://seekingalpha.com/currents/post/1355692\" target=\"_blank\">guidance</a>; at the time, CEO Rick Bergman stated new mobile product launches due in early 2014 would give his company a lift.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403352\" data-linked=\"Synaptics higher as Pac Crest reports of Galaxy S5 design win\" data-tweet=\"$SYNA $SYNA $ATML - Synaptics higher as Pac Crest reports of Galaxy S5 design win https://seekingalpha.com/news/1403352-synaptics-higher-as-pac-crest-reports-of-galaxy-s5-design-win?source=tweet\" data-url=\"https://seekingalpha.com/news/1403352-synaptics-higher-as-pac-crest-reports-of-galaxy-s5-design-win\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403322\" data-ts=\"1384183736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRX\" target=\"_blank\">CLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403322-collabrx-soars-on-quest-diagnostics-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CollabRx soars on Quest Diagnostics deal</a></h4><ul>\n<li>CollabRx (<a href=\"https://seekingalpha.com/symbol/CLRX\" title=\"CollabRx, Inc\">CLRX</a> <font color=\"green\">+29.5%</font>) is among the day's big gainers as the data analytics firm announces a multi-year deal with Quest Diagnostics (<a href=\"https://seekingalpha.com/symbol/DGX\" title=\"Quest Diagnostics Incorporated\">DGX</a> <font color=\"green\">+0.6%</font>).</li>\n<li>CLRX is providing a customized version of its Genetic Variant Annotation service for inclusion in DGX's clinical test reports. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403322\" data-linked=\"CollabRx soars on Quest Diagnostics deal\" data-tweet=\"$CLRX $CLRX $DGX - CollabRx soars on Quest Diagnostics deal https://seekingalpha.com/news/1403322-collabrx-soars-on-quest-diagnostics-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1403322-collabrx-soars-on-quest-diagnostics-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403272\" data-ts=\"1384183138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMR\" target=\"_blank\">IMMR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403272-immersion-logitech-higher-after-report-points-to-apple-haptics-efforts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immersion, Logitech higher after report points to Apple haptics efforts</a></h4><ul>\n<li>Haptic IP developer Immersion (<a href=\"https://seekingalpha.com/symbol/IMMR\" title=\"Immersion Corporation\">IMMR</a> <font color=\"green\">+2.7%</font>) is trading higher after a <a href=\"https://seekingalpha.com/currents/post/1402002\" target=\"_blank\">Bloomberg report</a> indicated Apple is thinking of integrating \"sensors that can distinguish heavy or light touches on the screen\" in iPhones launching after 2014. So is accessory/peripherals vendor Logitech (<a href=\"https://seekingalpha.com/symbol/LOGI\" title=\"Logitech International S.A.\">LOGI</a> <font color=\"green\">+2.3%</font>), which has released plenty of game controllers and mice supporting haptic feedback over the years, is also rallying.</li>\n<li>Logitech is getting set to launch an <a href=\"https://seekingalpha.com/currents/post/1309032\" target=\"_blank\">iPhone game controller</a>. Immersion struck a license deal with <a href=\"https://seekingalpha.com/currents/post/874281\" target=\"_blank\">Samsung</a> in March covering the use of basic haptic effects, and one in September with <a href=\"https://seekingalpha.com/currents/post/1263712\" target=\"_blank\">Xiaomi</a> that covers advanced features such as custom haptic effects for various apps.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403272\" data-linked=\"Immersion, Logitech higher after report points to Apple haptics efforts\" data-tweet=\"$IMMR $IMMR $LOGI - Immersion, Logitech higher after report points to Apple haptics efforts https://seekingalpha.com/news/1403272-immersion-logitech-higher-after-report-points-to-apple-haptics-efforts?source=tweet\" data-url=\"https://seekingalpha.com/news/1403272-immersion-logitech-higher-after-report-points-to-apple-haptics-efforts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403222\" data-ts=\"1384182103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDT\" target=\"_blank\">MDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403222-japan-approves-reimbursement-for-given-imagings-pillcam\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Japan approves reimbursement for Given Imaging&#39;s PillCam</a></h4><ul>\n<li>Japan's Central Social Insurance Medical Council approves reimbursement for Given Imaging's (GIVN <font color=\"green\">+1.7%</font>) PillCam COLON.</li>\n<li>Rate: ~$840/capsule, effective January 1. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403222\" data-linked=\"Japan approves reimbursement for Given Imaging&#39;s PillCam\" data-tweet=\"$MDT - Japan approves reimbursement for Given Imaging&#39;s PillCam https://seekingalpha.com/news/1403222-japan-approves-reimbursement-for-given-imagings-pillcam?source=tweet\" data-url=\"https://seekingalpha.com/news/1403222-japan-approves-reimbursement-for-given-imagings-pillcam\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403132\" data-ts=\"1384181032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGHT\" target=\"_blank\">EGHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403132-8x8-acquiring-u-k-hosted-voip-firm-issuing-new-stock-shares-plunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">8x8 acquiring U.K. hosted VoIP firm, issuing new stock; shares plunge</a></h4><ul>\n<li>8x8 (<a href=\"https://seekingalpha.com/symbol/EGHT\" title=\"8X8 Inc\">EGHT</a> <font color=\"red\">-9.8%</font>) is acquiring Voicenet Solutions, a provider of hosted/cloud-based VoIP and <a href=\"http://en.wikipedia.org/wiki/Unified_communications\" target=\"_blank\">unified communications</a> services to U.K. SMBs and mid-sized businesses, for $18.4M in cash. The deal is expected to close by year's end. (PR)</li>\n<li>Voicenet claims 1K+ customers. 8x8, thus far focused on North America, says the deal will give it an \"operational presence\" to help support U.S. customers, and will also allow Voicenet to offer a broader array of services. 8x8 is keeping its profit margin targets unchanged.</li>\n<li>8x8 is simultaneously announcing a 12.5M-share stock offering; at current levels, the offering would yield proceeds of $120M. Underwriters have the option to buy another 1.875M shares. For now, the company is tight-lipped regarding its plans for the proceeds.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403132\" data-linked=\"8x8 acquiring U.K. hosted VoIP firm, issuing new stock; shares plunge\" data-tweet=\"$EGHT - 8x8 acquiring U.K. hosted VoIP firm, issuing new stock; shares plunge https://seekingalpha.com/news/1403132-8x8-acquiring-u-k-hosted-voip-firm-issuing-new-stock-shares-plunge?source=tweet\" data-url=\"https://seekingalpha.com/news/1403132-8x8-acquiring-u-k-hosted-voip-firm-issuing-new-stock-shares-plunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403062\" data-ts=\"1384179708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403062-gogo-soars-on-beat-and-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo soars on beat and raise</a></h4><ul>\n<li>Shares of Gogo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GOGO\" title=\"Gogo\">GOGO</a>) soar <font color=\"green\">12.8%</font> in pre-market trading after the company handily beat expectations <a href=\"https://seekingalpha.com/currents/post/1402552\" target=\"_blank\">in Q3</a> and raised guidance for Q4.</li>\n<li>Commercial aviation revenue from North America expanded 53% Y/Y to $50.6M on the back of a 21% increase in connectivity take rate, a 15% increase in gross passengers potential, and an 8% increase in average revenue per session. Business Aviation revenue grew 42% Y/Y to $34.8M.</li>\n<li>Aircraft online included 2,011 CA-NA aircraft (+24% Y/Y) and 1,847 BA aircraft (+41% Y/Y).</li>\n<li>EBITDA expanded 251% Y/Y to $2M as loss from CA-NA dipped to $1.6M, profit from BA jumped to $14.6M, and CA-ROW loss increased to $11M as Gogo continued investments in international expansion.</li>\n<li>Management raises the top end of its full-year guidance range for revenue to $325M from $315M (vs. consensus of $311.2M) and EBITDA to $10M from $0M. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1403062\" data-linked=\"Gogo soars on beat and raise\" data-tweet=\"$GOGO - Gogo soars on beat and raise https://seekingalpha.com/news/1403062-gogo-soars-on-beat-and-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/1403062-gogo-soars-on-beat-and-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1403002\" data-ts=\"1384179129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1403002-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul><li> <b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLRX' title='CollabRx, Inc'>CLRX</a> <font color='green'>+56%</font>. <a href='https://seekingalpha.com/symbol/VPHM' title=''>VPHM</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> <font color='green'>+12%</font>. DSCO <font color='green'>+11%</font>. OXBT <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NAVB' title='Navidea Biopharmaceuticals'>NAVB</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/RDA' title='RDA Microelectronics, Inc.'>RDA</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NWBO' title='Northwest Biotherapeutics, Inc.'>OTCQB:NWBO</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='green'>+5%</font>. </li><li> <b>Losers:</b> ZLCS <font color='red'>-69%</font>. <a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color='red'>-9%</font>. </li></ul><div class=\"tiny-share-widget\" data-id=\"1403002\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$CLRX $SHPG $GOGO - Premarket Gainers / Losers https://seekingalpha.com/news/1403002-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1403002-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1402982\" data-ts=\"1384178972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPRS\" target=\"_blank\">EPRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1402982-zalicus-collapses-after-z160-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zalicus collapses after Z160 miss</a></h4><ul>\n<li>Zalicus (ZLCS) resumes trading on the heels of <a href=\"https://seekingalpha.com/currents/post/1402822\" target=\"_blank\">decisively bad news</a> for its  selective N-type calcium channel blocker <a href=\"https://seekingalpha.com/currents/search?query=Z160\" target=\"_blank\">Z160</a>.</li>\n<li>With development of the prospective chronic pain treatment discontinued, the company now looks to <a href=\"https://seekingalpha.com/currents/search?query=Z944\" target=\"_blank\">Z944</a> which, according to the Q3 PR, <a href=\"https://seekingalpha.com/currents/post/1382212\" target=\"_blank\">will enter</a> Phase 2 testing \"next year.\"</li>\n<li>ZLCS <strong><font color=\"red\">-68.4%</font></strong> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1402982\" data-linked=\"Zalicus collapses after Z160 miss\" data-tweet=\"$EPRS - Zalicus collapses after Z160 miss https://seekingalpha.com/news/1402982-zalicus-collapses-after-z160-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/1402982-zalicus-collapses-after-z160-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1402962\" data-ts=\"1384178730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCB\" target=\"_blank\">ARCB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1402962-arkansas-best-flies-after-smashing-q3-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arkansas Best flies after smashing Q3 estimates</a></h4><ul> <li>Shares of Arkansas Best (ABFS) jump higher after the company <a href=\"https://seekingalpha.com/currents/post/1402242\" target=\"_blank\">beats</a> estimates for Q3 handily.</li> <li>The company says its emerging business provided a nice lift during the quarter.</li> <li>ABFS <font color=\"green\">+10.2%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1402962\" data-linked=\"Arkansas Best flies after smashing Q3 estimates\" data-tweet=\"$ARCB - Arkansas Best flies after smashing Q3 estimates https://seekingalpha.com/news/1402962-arkansas-best-flies-after-smashing-q3-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/1402962-arkansas-best-flies-after-smashing-q3-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1402932\" data-ts=\"1384178494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLY\" target=\"_blank\">LLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1402932-goldman-downgrades-eli-lilly-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman downgrades Eli Lilly to Sell</a></h4><ul>\n<li>Goldman <a href=\"http://www.streetinsider.com/Analyst+Comments/Eli+Lilly+%28LLY%29+Cut+to+Sell+at+Goldman+Sachs/8868501.html\" target=\"_blank\">cuts</a> Eli Lilly (NYSE:<a href=\"https://seekingalpha.com/symbol/LLY\" title=\"Eli Lilly and Company\">LLY</a>) to Sell from Neutral.</li>\n<li>Same story here, patent expirations and a thin pipeline equate to an uncertain outlook. Here's analyst Jami Rubin: \"As LLY's primary care business declines due to patent expirations, the new product portfolio is increasingly important [but] we see a lack of differentiation for key pipeline products.\"</li>\n<li>Rubin also points to the stock's premium valuation relative to ABBV.</li>\n<li>Price target cut to $48 from $52.</li>\n<li>LLY <font color=\"red\">-1.5%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1402932\" data-linked=\"Goldman downgrades Eli Lilly to Sell\" data-tweet=\"$LLY - Goldman downgrades Eli Lilly to Sell https://seekingalpha.com/news/1402932-goldman-downgrades-eli-lilly-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/1402932-goldman-downgrades-eli-lilly-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1402892\" data-ts=\"1384178173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1402892-barclays-reports-cirrus-lost-ipad-amplifier-slot-shares-minus-6_3-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays reports Cirrus lost iPad amplifier slot, shares -6.3% premarket</a></h4><ul><li>Barclays says it <a href=\"https://twitter.com/thenotablecalls/status/399895373340102656\" target=\"_blank\">has confirmed</a> the iPad Air (unlike past iPad models) doesn't feature a Cirrus Logic (NASDAQ:<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a>) audio amplifier. Moreover, the firm thinks <a href=\"https://twitter.com/thenotablecalls/status/399896246204129280\" target=\"_blank\">there's a chance</a> Apple could stop using Cirrus' amplifiers altogether.</li><li>Cirrus remains Apple's iPad (and iPhone) audio codec chip supplier; <a href=\"http://www.ifixit.com/Teardown/iPad+Air+Teardown/18907\" target=\"_blank\">Air teardowns</a> have found a Cirrus codec chip inside. But with Apple believed to account for over 3/4 of Cirrus' revenue, the loss of amplifier sales would still be significant.</li><li>Barclays <a href=\"https://seekingalpha.com/currents/post/1370262\" target=\"_blank\">cut Cirrus to Underweight</a> two weeks ago, following the company's <a href=\"https://seekingalpha.com/currents/post/1365842\" target=\"_blank\">FQ2 results</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1402892\" data-linked=\"Barclays reports Cirrus lost iPad amplifier slot, shares -6.3% premarket\" data-tweet=\"$CRUS - Barclays reports Cirrus lost iPad amplifier slot, shares -6.3% premarket https://seekingalpha.com/news/1402892-barclays-reports-cirrus-lost-ipad-amplifier-slot-shares-minus-6_3-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1402892-barclays-reports-cirrus-lost-ipad-amplifier-slot-shares-minus-6_3-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1402882\" data-ts=\"1384177974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NNVC\" target=\"_blank\">NNVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1402882-nanoviricides-rallies-on-orphan-designation-for-dengue-fever-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NanoViricides rallies on Orphan designation for Dengue Fever treatment</a></h4><ul>\n<li>The EMA awards an Orphan designation to NanoViricides' (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/NNVC\" title=\"NanoViricides, Inc.\">NNVC</a>) Dengue Fever treatment DengueCide.</li>\n<li>The company reminds investors that \"an approved orphan medicine in the EMA countries is       expected to benefit from ten years of marketing exclusivity protection.\" If the drug is approved for both adults and children, market exclusivity can be extended to 12 years. (PR)</li>\n<li>NNVC <font color=\"green\">+9.9%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1402882\" data-linked=\"NanoViricides rallies on Orphan designation for Dengue Fever treatment\" data-tweet=\"$NNVC - NanoViricides rallies on Orphan designation for Dengue Fever treatment https://seekingalpha.com/news/1402882-nanoviricides-rallies-on-orphan-designation-for-dengue-fever-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/1402882-nanoviricides-rallies-on-orphan-designation-for-dengue-fever-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1402802\" data-ts=\"1384177278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1402802-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul>\n<li>Twitter (NYSE:<a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a>) has been started at Neutral by Sterne Agee. Shares <font color=\"red\">-1.4% </font>premarket after <font color=\"red\">dropping 7%</font> on Friday in the wake of neutral/bearish <a href=\"https://seekingalpha.com/currents/post/1400152\" target=\"_blank\">coverage launches</a>. Shares still <font color=\"green\">+58%</font> from their $26 IPO price.</li>\n<li>Veeva Systems (NYSE:<a href=\"https://seekingalpha.com/symbol/VEEV\" title=\"Veeva Systems Inc.\">VEEV</a>) has received four bullish ratings and two neutral ones on underwriter coverage day. Shares <font color=\"green\">+0.6%</font>.</li>\n<li>American Tower (NYSE:<a href=\"https://seekingalpha.com/symbol/AMT\" title=\"American Tower Corporation\">AMT</a>) has been upgraded to Buy by Citi.</li>\n<li>Youku (NYSE:<a href=\"https://seekingalpha.com/symbol/YOKU\" title=\"Youku Tudou Inc.\">YOKU</a>) has been upgraded to Buy by Brean ahead of Thursday's Q3 report. Shares <font color=\"green\">+3.1%</font>.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/BT\" title=\"BT Group plc\">BT</a> has been upgraded to Overweight by JPMorgan after <a href=\"https://seekingalpha.com/currents/post/1401932\" target=\"_blank\">outbidding Sky</a> for the U.K. TV rights to Champions League games.</li>\n<li>Netgear (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NTGR\" title=\"NETGEAR, Inc.\">NTGR</a>) has been upgraded to Sector Perform by RBC.</li>\n<li>Deutsche Telekom (<a href=\"https://seekingalpha.com/symbol/DTEGY\" title=\"Deutsche Telekom AG ADR\">OTCQX:DTEGY</a>, <a href=\"https://seekingalpha.com/symbol/DTEGF\" title=\"Deutsche Telekom AG\">OTCQX:DTEGF</a>) has been cut to Sell by Goldman after <a href=\"https://seekingalpha.com/currents/post/1402062\" target=\"_blank\">striking a $729M deal</a> to buy wireline carrier GTS Central Europe.</li>\n<li>Lam Research (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LRCX\" title=\"Lam Research Corporation\">LRCX</a>) has been cut to Neutral by Susquehanna.</li>\n<li>Diodes (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DIOD\" title=\"Diodes Incorporated\">DIOD</a>) has been cut to Outperform from Strong Buy by Raymond James ahead of tomorrow's Q3 report.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1402802\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$TWTR $TWTR $VEEV - A roundup of tech ratings changes https://seekingalpha.com/news/1402802-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1402802-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1402722\" data-ts=\"1384175811\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1402722-best-buy-tapped-for-more-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Best Buy tapped for more gains</a></h4><ul> <li>UBS <a href=\"https://twitter.com/Stephanie_Link/status/399878721248968704\" target=\"_blank\">upgrades</a> Best Buy (NYSE:<a href=\"https://seekingalpha.com/symbol/BBY\" title=\"Best Buy Co.\">BBY</a>) to a Buy rating from Neutral. Analysts with the firm say the BBY trade is not over with the retailer showing the potential to earn as much as $3.50 per share by 2015.</li> <li>Jefferies ups it price target to $52 from a previous level of $40.</li> <li>BBY <font color=\"green\">+2.3%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1402722\" data-linked=\"Best Buy tapped for more gains\" data-tweet=\"$BBY - Best Buy tapped for more gains https://seekingalpha.com/news/1402722-best-buy-tapped-for-more-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/1402722-best-buy-tapped-for-more-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1402492\" data-ts=\"1384172071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1402492-immunogen-signs-another-licensing-agreement-with-novartis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoGen signs another licensing agreement with Novartis</a></h4><ul>   <li>Novartis (NYSE:<a href=\"https://seekingalpha.com/symbol/NVS\" title=\"Novartis AG\">NVS</a>) has signed a third agreement this year to license ImmunoGen's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IMGN\" title=\"ImmunoGen, Inc.\">IMGN</a>) antibody-drug conjugate (ADC) technology to develop cancer therapies.</li>    <li>This is the fifth license that ImmunoGen has signed with a major healthcare company in 2013, with Eli Lilly and Amgen also using the tech.</li>     <li>The terms of the latest Novartis agreement are consistent with a license <a href=\"https://seekingalpha.com/currents/search?query=immunogen%20novartis\" target=\"_blank\">announced last month</a>. Under a 2010 agreement, the Swiss giant pays an upfront fee to ImmunoGen for each permit, milestone payments of up to $200M, and any royalties on sales.</li>     <li>Surprisingly, Immunogen's shares are <font color=\"red\">-4.2%.</font> (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1402492\" data-linked=\"ImmunoGen signs another licensing agreement with Novartis\" data-tweet=\"$NVS $NVS $IMGN - ImmunoGen signs another licensing agreement with Novartis https://seekingalpha.com/news/1402492-immunogen-signs-another-licensing-agreement-with-novartis?source=tweet\" data-url=\"https://seekingalpha.com/news/1402492-immunogen-signs-another-licensing-agreement-with-novartis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1402222\" data-ts=\"1384164820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1402222-world-stocks-trend-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">World stocks trend higher</a></h4><ul>   <li>\n<a href=\"http://online.wsj.com/news/articles/SB10001424052702303914304579191171008630170\" target=\"_blank\">Global equities</a> are mostly flat-to-higher following better-than-expected U.S. jobs numbers on Friday and decent economic data out of China over the weekend, and as the latter country's leaders discuss a major reform program at a four-day meeting.</li>    <li>Japan <font color=\"green\">+1.3%</font>, Hong Kong <font color=\"green\">+1.4%</font>, China <font color=\"green\">+0.2%</font>, India <font color=\"red\">-0.8%</font>.</li>    <li>EU Stoxx 50 <font color=\"green\">+0.1%</font>, London <font color=\"green\">+0.1%</font>, Paris <font color=\"green\">+0.1%</font>, Frankfurt flat, Milan <font color=\"green\">+0.1%</font>, Madrid <font color=\"red\">-0.2%</font>.</li>     <li>U.S. stock futures: Dow flat, S&amp;P flat, Nasdaq <font color=\"red\">-0.1%.</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1402222\" data-linked=\"World stocks trend higher\" data-tweet=\"World stocks trend higher https://seekingalpha.com/news/1402222-world-stocks-trend-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1402222-world-stocks-trend-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1402182\" data-ts=\"1384161046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPHE\" target=\"_blank\">EPHE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1402182-philippines-markets-hit-following-horrific-cyclone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Philippines markets hit following horrific cyclone</a></h4><ul>   <li>The Philippines Stock Exchange Index has <font color=\"red\">dropped 1.4%</font> and the peso has weakened following the immense devastation caused by Super Typhoon Haiyan, which is estimated to have killed <a href=\"http://www.reuters.com/article/2013/11/10/us-philippines-typhoon-idUSBRE9A603Q20131110\" target=\"_blank\">up to 10,000 people</a>.</li>    <li>The USD-PHP is <font color=\"green\">+1%</font> to 43.63 pesos, while 10-year government bond yields are +12 bps to 3.65%.</li>    <li>The concern is that the disaster will <a href=\"http://www.bloomberg.com/news/2013-11-11/philippine-peso-falls-with-stocks-on-typhoon-haiyan-devastation.html\" target=\"_blank\">hurt the Philippines' economy</a>, whose growth has topped 7% for four consecutive quarters. The damage caused is projected to reach an estimated $14B, of which $2B will be insured.</li>\n<li>ETF: <a href=\"https://seekingalpha.com/symbol/EPHE\" title=\"iShares MSCI Philippines ETF\">EPHE</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1402182\" data-linked=\"Philippines markets hit following horrific cyclone\" data-tweet=\"$EPHE - Philippines markets hit following horrific cyclone https://seekingalpha.com/news/1402182-philippines-markets-hit-following-horrific-cyclone?source=tweet\" data-url=\"https://seekingalpha.com/news/1402182-philippines-markets-hit-following-horrific-cyclone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 AM </div></div></li>","count":47,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}